Janssen-Cilag SpA
🇮🇹Italy
Non-interventional Study on Use of Darunavir With Ritonavir in Clinical Practice
Completed
- Conditions
- HIV Infections
- Interventions
- Drug: darunavir/ritonavir plus background regimen
- First Posted Date
- 2011-06-17
- Last Posted Date
- 2013-05-06
- Lead Sponsor
- Janssen-Cilag S.p.A.
- Target Recruit Count
- 31
- Registration Number
- NCT01375881
Paliperidone Extended Release in Schizophrenia Participants With Duration of Illness Less Than 10 Years
- First Posted Date
- 2011-05-30
- Last Posted Date
- 2013-06-05
- Lead Sponsor
- Janssen-Cilag S.p.A.
- Target Recruit Count
- 133
- Registration Number
- NCT01362439
Survey on QUality of Life In myeloDisplasia (SQUID)
Completed
- Conditions
- Myelodysplastic Syndromes
- Interventions
- Other: epidemiologic study
- First Posted Date
- 2009-08-28
- Last Posted Date
- 2014-04-28
- Lead Sponsor
- Janssen-Cilag S.p.A.
- Target Recruit Count
- 160
- Registration Number
- NCT00967564
A Study of the Safety and Effectiveness of Galantamine in Patients With Alzheimer's Disease
Phase 3
Completed
- Conditions
- Alzheimer DiseaseDementiaMental DisordersBrain Diseases
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2011-01-24
- Lead Sponsor
- Janssen-Cilag S.p.A.
- Target Recruit Count
- 254
- Registration Number
- NCT00216502
© Copyright 2025. All Rights Reserved by MedPath